Evidence map›Paper›PMID 9450958›Full record

ArticleMolecular biology of the cell1998

Inhibition of endosome fusion by wortmannin persists in the presence of activated Rab5.

A T Jones, I G Mills, A J Scheidig, K Alexandrov, M J Clague

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 48 citations in OpenAlex.

  1. Rab21 recruits EEA1 and competes with Rab5 for Rabex-5 activation.Frontiers in cell and developmental biology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Phagosome maturation: aging gracefully.The Biochemical journal · 2002
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Molecular aspects of the endocytic pathway.The Biochemical journal · 1998
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

A T JonesPhysiological Laboratory, University of Liverpool, Liverpool, L69 3BX, United Kingdom.
I G Mills
A J Scheidig
K Alexandrov
M J Clague
University of Liverpool · GBMax Planck Institute of Molecular Physiology · DE

Funding

Wellcome Trust
6 · The paper itself

Abstract

Rab5-dependent endosome fusion is sensitive to the phosphoinositide 3-kinase inhibitor, wortmannin. It has been proposed that phosphoinositide 3-kinase activity may be required for activation of rab5 by influencing its nucleotide cycle such as to promote its active GTP state. In this report we demonstrate that endosome fusion remains sensitive to wortmannin despite preloading of endosomes with stimulatory levels of a GTPase-defective mutant rab5(Q79L) or of a xanthosine triphosphate-binding mutant, rab5(D136N), in the presence of the nonhydrolysable analogue XTPgammaS. These results suggest that activation of rab5 cannot be the principal function of the wortmannin-sensitive factor on the endosome fusion pathway. This result is extrapolated to all GTPases by demonstrating that endosome fusion remains wortmannin sensitive despite prior incubation with the nonhydrolysable nucleotide analogue GTPgammaS. Consistent with these results, direct measurement of clathrin-coated vesicle-stimulated nucleotide dissociation from exogenous rab5 was insensitive to the presence of wortmannin. A large excess of rab5(Q79L), beyond levels required for maximal stimulation of the fusion assay, afforded protection against wortmannin inhibition, and partial protection was also observed with an excess of wild-type rab5 independent of GTPgammaS.

Indexed as

Alkyl and Aryl Transferasesrab GTP-Binding ProteinsAndrostadienesAnimalsCarrier ProteinsCell LineClathrinCoated VesiclesCricetinaeEndosomesEnzyme ActivationEnzyme InhibitorsGTP-Binding ProteinsGTP PhosphohydrolasesGuanosine 5'-O-(3-Thiotriphosphate)KidneyAlkyl and Aryl TransferasesAndrostadienesCarrier ProteinsClathrinEnzyme InhibitorsGTP-Binding ProteinsGTP PhosphohydrolasesGuanosine 5'-O-(3-Thiotriphosphate)Phosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase Inhibitorsrab5 GTP-Binding Proteinsrab GTP-Binding ProteinsRibonucleotidesWortmanninxanthosine 5'-triphosphate

Identifiers

PMID9450958
PMCPMC25257
OpenAlexW2023899397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.